On August 11, 2011
Pharma to Feds: Hands Off Our Medicare — and That $4.2B in Tax Breaks
The 2011 R&D credit has left drug companies paying tax rates as low as 8 percent. Merck, for instance, had no expenses for taxes in Q2 2011 — it managed to get a $382 million refund.
0 Comments